These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35467062)

  • 1. Association of Nrf2 expression and mutation with Weiss and Helsinki scores in adrenocortical carcinoma.
    Kamai T; Murakami S; Arai K; Ishida K; Kijima T
    Cancer Sci; 2022 Jul; 113(7):2368-2377. PubMed ID: 35467062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
    Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
    Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
    Blanes A; Diaz-Cano SJ
    Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
    Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
    J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of adrenocortical cancer.
    Lehmann T; Wrzesinski T
    Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
    Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
    Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
    Wang C; Sun Y; Wu H; Zhao D; Chen J
    Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.
    Nukui A; Narimatsu T; Kambara T; Abe H; Sakamoto S; Yoshida KI; Kamai T
    BMC Cancer; 2018 May; 18(1):493. PubMed ID: 29716554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
    Kamai T; Murakami S; Arai K; Nishihara D; Uematsu T; Ishida K; Kijima T
    BMC Cancer; 2022 Mar; 22(1):289. PubMed ID: 35300626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
    Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
    Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
    Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis.
    Stenman A; Murtha T; Korah R; Carling T
    Horm Metab Res; 2017 Aug; 49(8):631-637. PubMed ID: 28641336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.